News

Polypid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
The Company Anticipates that with this Additional Funding, PolyPid's Runway would be Extended beyond Anticipated U.S. Food and Drug Admi ...